Vitrectomy for diabetic vitreous hemorrhage

Visual outcomes and prognostic factors following pars plana vitrectomy for vitreous haemorrhage in patients with diabetic retinopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200312046750N1

Enrollment

130

Registered

2020-03-26

Start date

2012-01-01

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy. Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy

Interventions

Intervention consisted in pars plana vitrectomy (removal of the vitreous body). If needed, retinal endolaser (panretinal photocoagulation PRP or laser completion) was performed. Phacoemulsification wi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Non clearing vitreous hemorrhage for more than a month Severe diabetic retinopathy Treatment: pars plana vitrectomy Single surgeon experience

Exclusion criteria

Exclusion criteria: Follow-up less than 3 months Other macular diseases, advanced glaucoma History of ocular trauma History of pars plana vitrectomy for tractional retinal detachment

Design outcomes

Primary

Measure	Time frame
Postoperative best corrected visual acuity(BCVA). Timepoint: 3 months after pars plana vitrectomy. Method of measurement: Measurement of the visual acuity using Snellen chart.;Frequency of postoperative early and late vitreous hemorrhage. Timepoint: Early onset: 4 weeks. Method of measurement: Slit lamp and ophthalmoscopy.	—

Countries

Romania

Contacts

Public ContactIoana Damian

,,Iuliu Hatieganu" University of Medicine and Pharmacy

ioana.damian@umfcluj.ro+40 264 597 256

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026